JP Morgan Upgrades TSN Amid Analyst Target Cuts

Why this matters: JP Morgan upgraded TSN to Overweight today — a conviction call made even as the firm trimmed its price target. That upgrade lands against a backdrop of steadily falling targets across the Street and a stock down 11% over the past month.

Analysts Split on Direction

JP Morgan's Thomas Palmer moved TSN from Neutral to Overweight on September 18. He cut the target to $63 from $65 — still 21% above the current price of $52.26.

The upgrade is the standout. Every other recent action has been a target reduction, with no rating lift.

Piper Sandler's Michael Lavery cut to $66 from $78 on September 10, maintaining Overweight. BMO Capital and Barclays both trimmed targets on September 4. BMO went to $65 from $75. Barclays moved to $75 from $78. Neither changed their rating.

The consensus sits at Hold, with seven Hold ratings versus three Outperform/Overweight calls. The mean price target is $64.25 — implying the market is pricing in a 23% discount to where analysts think fair value sits.

Near-Term Headwinds Are Real

The bear case is not subtle. Analysts cite facility disruptions, New World Screwworm outbreaks, and potential weakness in beef and chicken margins. The Street has cut targets on TSN at nearly every opportunity since April.

The bull case leans on the chicken segment — still the strongest performer — international expansion, and a protein portfolio that diversifies commodity risk. JP Morgan's upgrade today backs that long-term framing while acknowledging the near-term noise.

Shorts Noticing, but Borrow Stays Loose

Short interest ticked up 15% over the past week to 2.9% of float. The cost to borrow jumped 59% in the same window, reaching 0.72%. These moves sound dramatic in percentage terms. In absolute terms, the borrow remains cheap and easy. Availability stands at 1,580% of short interest — roughly 241 million shares available versus 8.2 million shorted. There is no lending market squeeze here.

The incoming CEO-elect, Jeffrey Schomburger, bought $1 million of stock at $51.50 on September 4 — an open-market purchase, not a grant. That kind of discretionary buying from an executive taking the top job tends to carry signal.

Data Summary

• Price: $52.26, down 10.8% over one month
• Analyst consensus: Hold; mean target $64.25; 7 Holds, 3 Overweight/Outperform
• JP Morgan action (Sep 18): Upgraded to Overweight, target cut to $63 from $65
• Short interest: 2.9% of float, up 15% week-on-week
• Cost to borrow: 0.72%, up 59% week-on-week — still low in absolute terms
• Availability: 1,580% of short interest — borrow is abundant
• Insider: CEO-elect bought ~$1M in open-market shares on Sep 4
• Next earnings: November 9, 2026